title: Therapeutic use of erythropoietin in dermatooncology.
abstract: Erythropoietin has been successfully used in Europe since 1997 in the treatment of anemia induced by chemotherapy of solid tumors. There is only limited experience with regard to its use when treating dermatologic tumors such as metastatic melanoma. We review here current guidelines on the use of erythropoietin in cancer patients and report on our own melanoma patients treated with erythropoietin for chemotherapy-induced anemia.
authors: Department of Dermatology and Venereology, Skin Tumor Center, Hannover Medical School, Hannover, Germany. satzger.imke@mh-hannover.de
authors: Imke
authors: I
authors: Satzger
authors: Florian
authors: F
authors: Schenck
authors: Felicitas
authors: F
authors: Thol
authors: Arnold
authors: A
authors: Ganser
authors: Alexander
authors: A
authors: Kapp
authors: Ralf
authors: R
authors: Gutzmer
mesh_terms: D000740:Anemia / Q000139:chemically induced* / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003880:Dermatology / Q000379:methods / Q000592:standards / Q000639:trends; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D008495:Medical Oncology / Q000379:methods / Q000592:standards / Q000639:trends; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000639:trends; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D004921:Erythropoietin